Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
AstraZenecaFeb 19, 2020
EQTFeb 19, 2020
Getinge BFeb 19, 2020
ÅF Pöyry BFeb 19, 2020
BiotageFeb 19, 2020
Kurser & event 2020

OBS: Veckans aktietips 2020 är tillgängligt för prenumeranter på Investor-, Trader-, Professional- och Institutional-nivå hos Investtech.com. Kom ihåg att registrera dig!

OMX Stockholm PI (OMXSPI) developed positively Wednesday, and gained 1.19 percent to a close of 733 points. The index has thereby closed up seven out of the past eight days.

552 shares were up and 397 were down, while 71 remained unchanged, and there was no trading in 93 shares.

Total value of the trading volume for shares and primary capital certificates Wednesday was approximately 21.8 billion.

Embracer Group B (EMBRACB) closed at 107 kronor after a solid gain of 19.53 percent. The stock has never gained more in one day since Feb 14. 2018, when it was up 42.27 percent. The stock has thereby closed up seven out of the past eight days. The stock has by that gained 51.88 percent since the buy signal from rectangle formation two months ago. It was also very high volume. Overall it was traded for 624 millions kronor in the stock, which is 11 times as much as normal daily turnover.
Oasmia Pharmaceutical (OASM) closed at 7.39 kronor after a huge gain of 14.39 percent. The stock has now risen for the fifth day in a row and this past month the stock has gained as much as 42.76 percent. Technically it also looks good. The stock is trend wise positive in the medium term, has support at 6.30 kronor and a further increase is indicated.
SBB Norden B (SBBB) closed at 29.00 kronor after posting a gain of 5.84 percent. The previous time the stock gained this much was Nov 29. 2019, when it closed up 10.38 percent. The stock has thereby closed up 15 out of the past 16 days and this past month the stock has gained as much as 28.04 percent. Technically it also looks good. The stock is trend wise positive in the medium term, has support at 25.00 kronor and a further increase is indicated.
Klövern B (KLOVB) rose sharply to close at 26.52 kronor, up 4.41 percent. The stock has never gained more in one day since Feb 15. 2019, when it was up 4.62 percent. This past week the stock has gained as much as 10.32 percent. Technically it also looks good. The stock is trend wise positive in the medium term, has support at 18.50 kronor and a further increase is indicated.
Tele2 B (TEL2B) moved up and ended at 152 kronor, which is an increase of 1.47 percent. The stock has now risen for the seventh day in a row. It also looks good technically. The stock is trend wise positive in the medium term, has broken up through the resistance at 147 kronor and a further increase is indicated.

US 500 moderately up Wednesday
The market showed a small gain Wednesday, and S&P 500 (SP500) ended the day at 3386 points, which is an increase of 0.47 percent.

Indices
OMX Stockholm PI
   Positive Candidate
OMX Stockholm PI shows strong development within a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. The price has risen strongly since the positive signal from rectangle formation at the break through the resistance at 626. The objective at 682 is now met, but the formation still gives a signal in the same direction. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 626 points. The index is overall assessed as technically positive for the medium long term.
S&P 500
   Positive Candidate
Investors have paid higher prices over time to buy S&P 500 and the index is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 3020 points. RSI diverges negatively against the price, which indicates a danger for a reaction down. The index is overall assessed as technically positive for the medium long term.
Today's candidate
MedCap (MCAP) Price 211.00, Feb 19, 2020
MedCap has broken the rising trend up in the medium long term, which indicates an even stronger rising rate. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the stock has support at approximately 137 kronor. The short term momentum of the stock is strongly positive, with RSI above 70. This indicates increasing optimism among investors and further price increase for MedCap. The stock is overall assessed as technically positive for the medium long term.
Recommendation: Positive
Model Portfolio, Stockholmsbörsen
Portfolio:1512.79
Ref.idx:309.71
 Last week20202019
Portfolio   2.48%   8.88%   34.91%
Portfolio after commisio   2.48%   8.69%   32.31%
OMX Stockholm Benchmark GI   1.40%   8.00%   31.45%
Latest days indices
AEX0.60%629.20
ATX0.00%3406.09
CAC400.90%6111.24
COMPX0.87%9817.18
DAX0.79%13789
HEX0.98%10571.00
N1000.80%1182.10
OMXC25GI0.96%1467.51
OMXSPI1.19%732.67
OSEBX0.89%934.93
PSI200.87%5435.85
TECDAX1.90%3295.94
UKX1.02%7457.02
EURUSD-0.14%107.9250
CL (OIL)2.38%53.29
Indices Evaluations
 SML
AEXpospospos
ATXneutralneutralneutral
CAC40pospospos
COMPXpospospos
DAXpospospos
HEXpospospos
N100pospospos
OMXC25GIpospospos
OMXSPIpospospos
OSEBXposneutralpos
PSI20pospospos
TECDAXpospospos
UKXposposneutral
EURUSDnegnegneg
CL (OIL)neutralnegneg

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
Stockholmsbörsen - Medium term
 
      
40% 39% 21%
 471 Buy Candidates
 451 Neutral
 242 Sell Candidates
Track what the insiders are doing! Insider buys in green, insider sales in red.
 
   Last month:
   71% Positive
   198 Positive
   80 Negative
Cancel Analysis News
Disclaimer Copyright © 2020 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

[ Back to default newsletter setup ]

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK